In this clip from our recent panel, Dr. Chalmers shares about his experience using Xstrahl’s Small Animal Radiation Research Platform (SARRP) to research rectal cancer.
CIX3 used in HER2-positive Tumor Research
See what researchers found in the recent study: Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2‑positive murine tumor. See the original publication here.
